Joseph Piven is Thomas E. Castelloe Distinguished Professor of Psychiatry and director of the Carolina Institute for Developmental Disabilities at the University of North Carolina at Chapel Hill. He is also director of the NIH Autism Center of Excellence Network’s Infant Brain Imaging Study (IBIS). He served on the American Psychiatric Association committee that wrote the new definition of autism spectrum disorder for the DSM-5.
Joseph Piven
Professor
University of North Carolina at Chapel Hill
From this contributor
Correcting the record: Leo Kanner and the broad autism phenotype
The specter of the ‘refrigerator mother’ theory continues to haunt the history of autism. New information puts Kanner’s observations of parents into context.
Correcting the record: Leo Kanner and the broad autism phenotype
By
James Harris, Joseph Piven
26 April 2016 | 10 min read
Explore more from The Transmitter
Watching the mind build a world: Lucid dreaming as a model for generative perception
Lucid dreaming offers a rare opportunity to observe and probe perception from within.
Watching the mind build a world: Lucid dreaming as a model for generative perception
Lucid dreaming offers a rare opportunity to observe and probe perception from within.
By
Magdalena Paluchowska
13 July 2026 | 8 min read
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
By
Natalia Mesa
9 July 2026 | 5 min read
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read